These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 1682645

  • 1. Safety and immunogenicity of Pseudomonas aeruginosa conjugate A vaccine in cystic fibrosis.
    Schaad UB, Lang AB, Wedgwood J, Ruedeberg A, Que JU, Fürer E, Cryz SJ.
    Lancet; 1991 Nov 16; 338(8777):1236-7. PubMed ID: 1682645
    [Abstract] [Full Text] [Related]

  • 2. Immunization of cystic fibrosis patients with a Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccine.
    Cryz SJ, Lang A, Rüdeberg A, Wedgwood J, Que JU, Fürer E, Schaad U.
    Behring Inst Mitt; 1997 Feb 16; (98):345-9. PubMed ID: 9382759
    [Abstract] [Full Text] [Related]

  • 3. A polyvalent Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccine.
    Cryz SJ, Fürer E, Sadoff JC, Germanier R.
    Antibiot Chemother (1971); 1987 Feb 16; 39():249-55. PubMed ID: 3118786
    [No Abstract] [Full Text] [Related]

  • 4. Antibody responses induced by long-term vaccination with an octovalent conjugate Pseudomonas aeruginosa vaccine in children with cystic fibrosis.
    Zuercher AW, Horn MP, Que JU, Ruedeberg A, Schoeni MH, Schaad UB, Marcus P, Lang AB.
    FEMS Immunol Med Microbiol; 2006 Jul 16; 47(2):302-8. PubMed ID: 16831219
    [Abstract] [Full Text] [Related]

  • 5. Effect of high-affinity anti-Pseudomonas aeruginosa lipopolysaccharide antibodies induced by immunization on the rate of Pseudomonas aeruginosa infection in patients with cystic fibrosis.
    Lang AB, Schaad UB, Rüdeberg A, Wedgwood J, Que JU, Fürer E, Cryz SJ.
    J Pediatr; 1995 Nov 16; 127(5):711-7. PubMed ID: 7472821
    [Abstract] [Full Text] [Related]

  • 6. Increased levels of IgG subclasses specific for Pseudomonas aeruginosa exoenzyme and polysaccharide antigens in chronically infected patients with cystic fibrosis.
    Albus A, Saalmann M, Tesch H, Pedersen SS, Döring G.
    APMIS; 1989 Dec 16; 97(12):1146-8. PubMed ID: 2482060
    [Abstract] [Full Text] [Related]

  • 7. Prospective study of serum antibodies to Pseudomonas aeruginosa exoproteins in cystic fibrosis.
    Hollsing AE, Granström M, Vasil ML, Wretlind B, Strandvik B.
    J Clin Microbiol; 1987 Oct 16; 25(10):1868-74. PubMed ID: 3117842
    [Abstract] [Full Text] [Related]

  • 8. Is Pseudomonas aeruginosa exotoxin A a good carrier protein for conjugate vaccines?
    Pier GB.
    Hum Vaccin; 2007 Oct 16; 3(2):39-40; author reply 41. PubMed ID: 17268204
    [No Abstract] [Full Text] [Related]

  • 9. Safety and immunogenicity of Staphylococcus aureus type 5 capsular polysaccharide-Pseudomonas aeruginosa recombinant exoprotein A conjugate vaccine in patients on hemodialysis.
    Welch PG, Fattom A, Moore J, Schneerson R, Shiloach J, Bryla DA, Li X, Robbins JB.
    J Am Soc Nephrol; 1996 Feb 16; 7(2):247-53. PubMed ID: 8785394
    [Abstract] [Full Text] [Related]

  • 10. A multicomponent Pseudomonas aeruginosa vaccine consisting of toxoids of protease, elastase, exotoxin A and a common protective antigen (OEP). Application in patients with diffuse panbronchiolitis.
    Homma JY, Tanimoto H.
    Antibiot Chemother (1971); 1987 Feb 16; 39():215-21. PubMed ID: 3118783
    [No Abstract] [Full Text] [Related]

  • 11. Safety and immunogenicity of Vi conjugate vaccines for typhoid fever in adults, teenagers, and 2- to 4-year-old children in Vietnam.
    Kossaczka Z, Lin FY, Ho VA, Thuy NT, Van Bay P, Thanh TC, Khiem HB, Trach DD, Karpas A, Hunt S, Bryla DA, Schneerson R, Robbins JB, Szu SC.
    Infect Immun; 1999 Nov 16; 67(11):5806-10. PubMed ID: 10531232
    [Abstract] [Full Text] [Related]

  • 12. Synthesis and characterization of a Pseudomonas aeruginosa alginate-toxin A conjugate vaccine.
    Cryz SJ, Fürer E, Que JU.
    Infect Immun; 1991 Jan 16; 59(1):45-50. PubMed ID: 1898901
    [Abstract] [Full Text] [Related]

  • 13. Reaction of antibody in sera from cystic fibrosis patients with non-toxic forms of Pseudomonas aeruginosa exotoxin A.
    Klinger KW, Shuster CW, Klinger J.
    Eur J Clin Microbiol; 1985 Apr 16; 4(2):201-6. PubMed ID: 3924609
    [Abstract] [Full Text] [Related]

  • 14. [Antibody titers in the serum of patients vaccinated with the multicomponent vaccine consisting of toxoids of protease, elastase and a common protective antigen (OEP)].
    Yamamoto M, Kubota Y, Matsuura M, Homma JY.
    Kansenshogaku Zasshi; 1986 Nov 16; 60(11):1178-83. PubMed ID: 3102639
    [No Abstract] [Full Text] [Related]

  • 15. Effect of immunisation with Pseudomonas aeruginosa on gut-derived sepsis in mice.
    Matsumoto T, Tateda K, Miyazaki S, Furuya N, Ohno A, Ishii Y, Hirakata Y, Yamaguchi K.
    J Med Microbiol; 1998 Apr 16; 47(4):295-301. PubMed ID: 9568994
    [Abstract] [Full Text] [Related]

  • 16. Clearance of Pseudomonas aeruginosa from normal rat lungs after immunization with somatic antigens or toxin A.
    Johansen HK, Cryz SJ, Høiby N.
    APMIS; 1994 Jul 16; 102(7):545-53. PubMed ID: 7917224
    [Abstract] [Full Text] [Related]

  • 17. Safety and immunogenicity of Escherichia coli O18 O-specific polysaccharide (O-PS)-toxin A and O-PS-cholera toxin conjugate vaccines in humans.
    Cryz SJ, Cross AS, Sadoff JC, Wegmann A, Que JU, Fürer E.
    J Infect Dis; 1991 May 16; 163(5):1040-5. PubMed ID: 1708398
    [Abstract] [Full Text] [Related]

  • 18. Immunization of noncolonized cystic fibrosis patients against Pseudomonas aeruginosa.
    Cryz SJ, Wedgwood J, Lang AB, Ruedeberg A, Que JU, Fürer E, Schaad UB.
    J Infect Dis; 1994 May 16; 169(5):1159-62. PubMed ID: 8169414
    [Abstract] [Full Text] [Related]

  • 19. Cloning, expression and characterization of recombinant exotoxin A-flagellin fusion protein as a new vaccine candidate against Pseudomonas aeruginosa infections.
    Tanomand A, Farajnia S, Najar Peerayeh S, Majidi J.
    Iran Biomed J; 2013 May 16; 17(1):1-7. PubMed ID: 23279828
    [Abstract] [Full Text] [Related]

  • 20. Octavalent Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccine.
    Cryz SJ, Sadoff JC, Fürer E.
    Microb Pathog; 1989 Jan 16; 6(1):75-80. PubMed ID: 2733597
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.